AI Visibility Scorecard
tecelra.com · Healthcare
Somewhat visible. AI bots can read TECELRA (afamitresgene autoleucel) Patient Website, but it is missing the structured signals that push citation rate above competitors.
AI engines read this profile 5 times
Claude · Apple Intelligence · Meta AI
#188,841 of 923,184 in Healthcare for AI visibility
5
AEO Visibility
iBorderline · 5.4/10
0
Muse Index Score
iAI agent readiness
Not agent-ready · 0/100
0
AI Adoption
iNone detected · 0/100
from our crawl and measurement
TECELRA (afamitresgene autoleucel) Patient Website is a business whose own site puts it this way: "TECELRA (afamitresgene autoleucel) for certain adults with advanced synovial sarcoma. See safety info incl Important Warning about severe side effects and monitoring." To AI engines like ChatGPT and Perplexity it is partially visible, scoring 5.8 out of 10, readable in places, missing in others.
Our crawl found a readable heading structure. It also found the gaps that keep answer engines guessing: structured data describing the business, an llms.txt file, a sitemap.
AI crawlers have visited the site once in our tracking, so the engines are already looking.
Strong · Good · Fair · Weak
Structured Data
Weak
Organization / LocalBusiness JSON-LD that AI can read.
Content Structure
Strong
Clear headings and answer-style content.
Entity Clarity
Good
How clearly your brand identity reads to AI.
E-E-A-T Signals
Experience, Expertise, Authority, Trust
Weak
Experience, Expertise, Authority, Trust markers.
Technical AEO
Fair
robots.txt, llms.txt, and AI-bot crawl access.
AI Discoverability
Strong
Sitemaps and entity links AI can follow.
How the web signals your brand to AI
Backlinks
Strong
Inbound links from other sites.
Domain Authority
Weak
Little domain authority yet.
Reference Presence
Weak
Not in AI knowledge graphs yet.
News & Press
Weak
No press coverage found yet.
Community
Weak
No community discussion yet.
Social Mentions
Weak
No social discussion found yet.
Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 5.4/10, TECELRA (afamitresgene autoleucel) Patient Website has a working base to build on - fixable, and the signals above are where to start.
What are you most interested in exploring about TECELRA?
A different way to treat advanced synovial sarcoma has emerged. Use the links to dive into the TECELRA story and the topics you want to learn about.
What is TECELRA?
TECELRA is a medicine, called a genetically modified autologous T cell immunotherapy, that is used to treat synovial sarcoma. It is used when other kinds of treatment do not work. TECELRA is different from other cancer medicines because it is made from your own white blood cells that are made to recognize and attack your cancer cells. Your healthcare provider will perform tests to see if TECELRA is right for you.
Is this your brand?
The exact fixes for TECELRA (afamitresgene autoleucel) Patient Website
Which AI engines already crawl you
Free AI bot monitoring: see every AI crawler that visits you
The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for TECELRA (afamitresgene autoleucel) Patient Website.
Scored by Engagemii on August 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/tecelra
Cite this score: Engagemii (2026). "AEO Score for TECELRA (afamitresgene autoleucel) Patient Website." Retrieved from https://engagemii.com/aeo/brands/tecelra
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform